Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuronetics ( (STIM) ) has issued an update.
On February 23, 2026, Neuronetics, Inc.’s board, acting on the recommendation of its Compensation Committee, approved annual cash incentive awards for senior executives tied to 2025 performance. The payments, totaling more than $649,000 for the chief executive, chief financial, and chief legal officers, are scheduled to be made on or about March 13, 2026.
The compensation awards to CEO Keith J. Sullivan, CFO Steven E. Pfanstiel, and Chief Legal Officer W. Andrew Macan underscore the board’s support for existing leadership and its use of variable pay to reward recent operational and financial execution. The decision signals continuity in Neuronetics’ executive team and incentive structure, which may be relevant to investors tracking management stability and governance practices.
The most recent analyst rating on (STIM) stock is a Buy with a $5.50 price target. To see the full list of analyst forecasts on Neuronetics stock, see the STIM Stock Forecast page.
Spark’s Take on STIM Stock
According to Spark, TipRanks’ AI Analyst, STIM is a Neutral.
The score is held down primarily by weak financial durability (large losses, negative cash flow, and higher leverage) and bearish technicals (price below major moving averages with negative MACD). The latest earnings call provides some offset via strong reported revenue growth and improving cash burn with a near-term breakeven cash flow target, but margin pressure and reduced guidance keep the outlook cautious.
To see Spark’s full report on STIM stock, click here.
More about Neuronetics
Neuronetics, Inc. operates in the medical technology industry, focusing on neuromodulation treatments for psychiatric and neurological disorders. The company’s primary offerings are device-based therapies aimed at improving outcomes for patients with mental health conditions, positioning it within the broader market for innovative brain health solutions.
Average Trading Volume: 1,882,075
Technical Sentiment Signal: Sell
Current Market Cap: $86.98M
Learn more about STIM stock on TipRanks’ Stock Analysis page.